Table 1.
MSI-H CRC patients, healthy Lynch syndrome mutation carriers and healthy controls.
| patients | mutation carriers |
healthy controls |
|
|---|---|---|---|
| total n | 69 | 31 | 52 |
| median age (years) | 50 | 38 | 48 |
| age range | 28–78 | 25–75 | 27–80 |
| % male | 61.8 | 41.9 | 61.0 |
| UICC stage | |||
| 1 | 10 (14.5%) | - | - |
| 2 | 20 (29.0%) | - | - |
| 3 | 14 (20.3%) | - | - |
| unknown | 25 (36.2%) | - | - |
| time after tumor resection | |||
| 2 months | 5 (7.2%) | - | - |
| 3 months to 12 months | 7 (10.1%) | - | - |
| 13 months to 48 months | 19 (27.5%) | - | - |
| 49 months to 96 months | 20 (29.0%) | - | - |
| >96 months | 7 (10.1%) | - | - |
| unknown | 11 (15.9%) | - | - |